Responses
Clinical/translational cancer immunotherapy
Original research
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers
Compose a Response to This Article
Other responses
No responses have been published for this article.
